Daniel Rosenblum

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Daniel Rosenblum, Anna Gutkin, Ranit Kedmi et al. · Science Advances · 2020 · 584 citations · Full text

Life Sciences, Biotechnology, Oncology +17

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes

Nuphar Veiga, Meir Goldsmith, Yasmin Granot et al. · Nature Communications · 2018 · 299 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes

Inbal Hazan‐Halevy, Daniel Rosenblum, Shiri Weinstein et al. · Cancer Letters · 2015 · 148 citations

Life Sciences, Cell Biology, Oncology +14

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies

Shiri Weinstein, Itai Antoine Toker, Rafi Emmanuel et al. · Proceedings of the National Academy of Sciences · 2015 · 95 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

End points to establish the efficacy of new agents in the treatment of acute leukemia

Frederick R. Appelbaum, Daniel Rosenblum, R.J. Arceci et al. · Blood · 2006 · 91 citations · Full text

Medicine, Hematology, Oncology +9